181 related articles for article (PubMed ID: 20574452)
1. Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.
Daniels TR; Neacato II; Rodríguez JA; Pandha HS; Morgan R; Penichet ML
Leukemia; 2010 Sep; 24(9):1555-65. PubMed ID: 20574452
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
Suzuki E; Daniels TR; Helguera G; Penichet ML; Umezawa K; Bonavida B
Int J Oncol; 2010 May; 36(5):1299-307. PubMed ID: 20372806
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
Daniels-Wells TR; Widney DP; Leoh LS; Martínez-Maza O; Penichet ML
J Immunother; 2015 Oct; 38(8):307-10. PubMed ID: 26325374
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
Daniels-Wells TR; Helguera G; Rodríguez JA; Leoh LS; Erb MA; Diamante G; Casero D; Pellegrini M; Martínez-Maza O; Penichet ML
Toxicol In Vitro; 2013 Feb; 27(1):220-31. PubMed ID: 23085102
[TBL] [Abstract][Full Text] [Related]
5. An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Daniels TR; Ortiz-Sánchez E; Luria-Pérez R; Quintero R; Helguera G; Bonavida B; Martínez-Maza O; Penichet ML
J Immunother; 2011; 34(6):500-8. PubMed ID: 21654517
[TBL] [Abstract][Full Text] [Related]
6. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
7. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
8. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
Alharbi RA; Pandha HS; Simpson GR; Pettengell R; Poterlowicz K; Thompson A; Harrington K; El-Tanani M; Morgan R
Oncotarget; 2017 Oct; 8(52):89566-89579. PubMed ID: 29163771
[TBL] [Abstract][Full Text] [Related]
10. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
11. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
Platais C; Radhakrishnan R; Niklander Ebensperger S; Morgan R; Lambert DW; Hunter KD
BMC Cancer; 2018 Jul; 18(1):723. PubMed ID: 29980182
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
Ortiz-Sánchez E; Daniels TR; Helguera G; Martinez-Maza O; Bonavida B; Penichet ML
Leukemia; 2009 Jan; 23(1):59-70. PubMed ID: 18946492
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of specific HOX gene expression patterns in ovarian cancer.
Kelly Z; Moller-Levet C; McGrath S; Butler-Manuel S; Kavitha Madhuri T; Kierzek AM; Pandha H; Morgan R; Michael A
Int J Cancer; 2016 Oct; 139(7):1608-17. PubMed ID: 27225067
[TBL] [Abstract][Full Text] [Related]
14. Expression of homeobox genes in human erythroleukemia cells.
Shen WF; Largman C; Lowney P; Hack FM; Lawrence HJ
Adv Exp Med Biol; 1989; 271():211-9. PubMed ID: 2577240
[TBL] [Abstract][Full Text] [Related]
15. Expression of selected human HOX-2 genes in B/T acute lymphoid leukemia and interleukin-2/interleukin-1 beta-stimulated natural killer lymphocytes.
Petrini M; Quaranta MT; Testa U; Samoggia P; Tritarelli E; Carè A; Cianetti L; Valtieri M; Barletta C; Peschle C
Blood; 1992 Jul; 80(1):185-93. PubMed ID: 1351762
[TBL] [Abstract][Full Text] [Related]
16. Altered HOX gene expression in human skin and breast cancer cells.
Svingen T; Tonissen KF
Cancer Biol Ther; 2003; 2(5):518-23. PubMed ID: 14614318
[TBL] [Abstract][Full Text] [Related]
17. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
Daniels TR; Ng PP; Delgado T; Lynch MR; Schiller G; Helguera G; Penichet ML
Mol Cancer Ther; 2007 Nov; 6(11):2995-3008. PubMed ID: 18025284
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis.
Cillo C; Cantile M; Mortarini R; Barba P; Parmiani G; Anichini A
Int J Cancer; 1996 May; 66(5):692-7. PubMed ID: 8647634
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.
Leoh LS; Kim YK; Candelaria PV; Martínez-Maza O; Daniels-Wells TR; Penichet ML
J Immunol; 2018 May; 200(10):3485-3494. PubMed ID: 29654211
[TBL] [Abstract][Full Text] [Related]
20. Lineage and stage specific expression of HOX 1 genes in the human hematopoietic system.
Vieille-Grosjean I; Roullot V; Courtois G
Biochem Biophys Res Commun; 1992 Mar; 183(3):1124-30. PubMed ID: 1348930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
